Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents

Pediatric Drugs

Volumn 14, Issue 2, 2012, Pages 91-108

  Bailey, Steffani R ^a   Crew, Erin E ^b   Riske, Emily C ^b   Ammerman, Seth ^b   Robinson, Thomas N ^b   Killen, Joel D ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescents; Bupropion; Nicotine replacement therapy; Smoking cessation therapies; Smoking withdrawal; Varenicline.

Indexed keywords

AMFEBUTAMONE; NICOTINE; NICOTINE GUM; NICOTINE PATCH; VARENICLINE;

ABNORMAL DREAMING; ADOLESCENT SMOKING; AGITATION; ANXIETY; BEHAVIOR CHANGE; BLURRED VISION; CARDIOVASCULAR SYMPTOM; CLINICAL PROTOCOL; CONFUSION; CONSTIPATION; COUGHING; DECREASED APPETITE; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; EDEMA; ERYTHEMA; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART PALPITATION; HEARTBURN; HICCUP; HUMAN; INSOMNIA; IRRITABILITY; JAW PAIN; LUNG DISEASE; MUSCLE DISEASE; NASAL PRURITUS; NAUSEA; NICOTINE REPLACEMENT THERAPY; OPEN STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; REVIEW; SHOULDER PAIN; SIDE EFFECT; SMELLING DISORDER; SMOKING CESSATION; SORE THROAT; TASTE DISORDER; TREMOR; VIRUS INFECTION; VOMITING;

ADOLESCENT; BENZAZEPINES; BUPROPION; CLINICAL TRIALS AS TOPIC; DOPAMINE UPTAKE INHIBITORS; HUMANS; NICOTINE; NICOTINIC AGONISTS; PATIENT COMPLIANCE; PRESCRIPTION DRUGS; QUINOXALINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SAFETY; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE CESSATION PRODUCTS; TREATMENT OUTCOME;

EID: 84857249934     PISSN: 11745878     EISSN: 11792019     Source Type: Journal    
DOI: 10.2165/11594370-000000000-00000     Document Type: Review

References (38)

1. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Healthy People 2020: proposed HP2020 objectives [online]. Available from URL: http://www.healthypeople.gov/hp2020 [Accessed 2011 Feb 1].
2. Substance Abuse and Mental Health Service Administration, Office of Applied Studies. The NSDUH report. Trends in substance use, dependence or abuse, and treatment among adolescents: 2002-2007. Rockville (MD): Substance Abuse and Mental Health Service Administration, 2008 Dec 4
3. Johnston LD, OMalley PM, Bachman JG, et al. Monitoring the Future national results on adolescent drug use: overview of key findings, 2009. NIH publication no. 10-7583. Bethesda (MD): National Institute on Drug Abuse, 2010
4. Department of Health and Human Services. Preventing tobacco use among young people: a report of the Surgeon General (DHHS publication no. CDC 89-8411). Washington, DC: U.S. Government Printing Office, 1994.
5. Fiore MC, Jaén CR, Baker TB, et al. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Rockville (MD): U.S. Department of Health and Human Services, 2008 May
6. Bailey SR, Harrison CT, Jeffery CJ, et al. Withdrawal symptoms over time among adolescents in a smoking cessation intervention: do symptoms vary by level of nicotine dependence? Addict Behav 2009; 34 (12): 1017-22
7. Killen JD, Ammerman S, Rojas N, et al. Do adolescent smokers experience withdrawal effects when deprived of nicotine? Exp Clin Psychopharmacol 2001; 9 (2): 176-82 (Pubitemid 32852318)
8. Colby SM, Tiffany ST, Shiffman S, et al. Are adolescent smokers dependent on nicotine? A review of the evidence. Drug Alcohol Depend 2000; 59 Suppl. 1: S83-95
9. Rojas NL, Killen JD, Haydel KF, et al. Nicotine dependence among adolescent smokers. Arch Pediatr Adolesc Med 1998; 152 (2): 151-6 (Pubitemid 28090788)
10. Hanson K, Zylla E, Allen S, et al. Cigarette reduction: an intervention for adolescent smokers. Drug Alcohol Depend 2008; 95 (1-2): 164-8
11. Fiore MC, Smith SS, Jorenby DE, et al. The effectiveness of the nicotine patch for smoking cessation: a meta-analysis. JAMA 1994; 271 (24): 1940-7
12. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008; (1): CD000146
13. Hudmon KS, Corelli RL, Prokhorov AV. Current approaches to pharmacotherapy for smoking cessation. Ther Adv Respir Dis 2010; 4 (1): 35-47
14. Smith TA, House Jr RF, Croghan IT, et al. Nicotine patch therapy in adolescent smokers. Pediatrics 1996; 98 (4): 659-67
15. Hurt RD, Croghan GA, Beede SD, et al. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels. Arch Pediatr Adolesc Med 2000; 154 (1): 31-7 (Pubitemid 30027652)
16. Hanson K, Allen S, Jensen S, et al. Treatment of adolescent smokers with the nicotine patch. Nicotine Tob Res 2003; 5 (4): 515-26 (Pubitemid 37081132)
17. Roddy E, Romilly N, Challenger A, et al. Use of nicotine replacement therapy in socioeconomically deprived young smokers: a community-based pilot randomised controlled trial. Tob Control 2006; 15: 373-6 (Pubitemid 44606731)
18. Moolchan ET, Robinson ML, Ernst M, et al. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction. Pediatrics 2005; 115 (4): e407-14
19. Rubinstein ML, Benowitz NL, Auerback GM, et al. A randomized trial of nicotine nasal spray in adolescent smokers. Pediatrics 2008; 122 (3): e595-600
20. Upadhyaya HP, Brady KT, Wang W. Bupropion SR in adolescents with comorbid ADHD and nicotine dependence: a pilot study. J Am Acad Child Adolesc Psychiatry 2004; 43 (2): 199-205
21. Niederhofer H, Huber M. Bupropion may support psychosocial treatment of nicotine-dependent adolescents: preliminary results. Pharmacotherapy 2004; 24 (11): 1524-8 (Pubitemid 39426348)
22. Killen JD, Robinson TN, Ammerman S, et al. Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers. J Consult Clin Psychol 2004; 72 (4): 729-35 (Pubitemid 38988850)
23. Muramoto ML, Leischow SJ, Sherrill D, et al. Randomized, double-blind, placebo-controlled trial of 2 dosages of sustained-release bupropion for adolescent smoking cessation. Arch Pediatr Adolesc Med 2007; 161 (11): 1068-74 (Pubitemid 350074839)
24. Gray KM, Carpenter MJ, Baker NL, et al. Bupropion SR and contingency management for adolescent smoking cessation. J Subst Abuse Treat 2011; 40 (1): 77-86
25. CHANTIX- (varenicline) tablets: US prescribing information. New York: Pfizer Labs, 2010
26. Mills EJ, Wu P, Lockhart I, et al. Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation: a systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. Tob Induc Dis 2010; 8 (8): 1-15
27. Faessel H, Ravva P, Williams K. Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: a multicenter, randomized, doubleblind, placebo-controlled, parallel-group study. Clin Ther 2009; 31 (1): 177-89
28. Slotkin TA. Nicotine and the adolescent brain: insights from an animal model. Neurotoxicol Teratol 2002; 24 (3): 369-84 (Pubitemid 34495468)
29. Slotkin TA. If nicotine is a developmental neurotoxicant in animal studies, dare we recommend nicotine replacement therapy in pregnant women and adolescents? Neurotoxicol Teratol 2008; 30 (1): 1-19
30. Slemmer JE, Martin BR, Damaj MI. Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther 2000; 295 (1): 321-7
31. ZYBAN- (bupropion hydrochloride) sustained-released tablets: US prescribing information. Research Triangle Park (NC): GlaxoSmithKline, 2010
32. Ossip-Klein DJ, Bigelow G, Curry S, et al. Task force 1: classification and assessment of smoking behavior. Health Psychol 1986; 5 Suppl.: 3-11
33. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007; (1): CD000031
34. Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997; 337 (17): 1195-202 (Pubitemid 27454451)
35. Swan GE, McAfee T, Curry SJ, et al. Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial. Arch Intern Med 2003; 163 (19): 2337-44 (Pubitemid 37310195)
36. Wagner KD. Pharmacotherapy for major depression in children and adolescents. Prog in Neuropsychopharmacol Biol Psychiatry 2005; 29 (5): 819-26 (Pubitemid 40897799)
37. Rollema H, Chambers LK, Coe JW, et al. Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 2007; 52 (3): 985-94 (Pubitemid 46227486)
38. Sussman S, Sun P, Dent CW. A meta-analysis of teen cigarette smoking cessation. Health Psychol 2006; 25 (5): 549-57 (Pubitemid 44600915)